DIFFUSE LARGE CELL NON HODGKINS LYMPHOMA

Clinical trials for DIFFUSE LARGE CELL NON HODGKINS LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new DIFFUSE LARGE CELL NON HODGKINS LYMPHOMA trials appear

Sign up with your email to follow new studies for DIFFUSE LARGE CELL NON HODGKINS LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug combo aims to make stem cell transplants safer for blood cancer patients

Disease control Recruiting now

This Phase 2 trial is testing a stem cell transplant from a donor for people with various blood cancers and bone marrow disorders. The transplant uses strong chemotherapy or radiation to wipe out the diseased marrow, then replaces it with healthy donor cells. A new combination of…

Matched conditions: DIFFUSE LARGE CELL NON HODGKINS LYMPHOMA

Phase: PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control

Last updated Jun 27, 2026 14:03 UTC

DIFFUSE LARGE CELL NON HODGKINS LYMPHOMA

Get alerted when new DIFFUSE LARGE CELL NON HODGKINS LYMPHOMA trials appear

New drug combo aims to make stem cell transplants safer for blood cancer patients